Tremor is one of the most common symptoms of Parkinson's disease (PD), assessed using clinician-assigned clinical scales, which can be subjective and prone to variability. This study evaluates the potential of unsupervised learning for the classification and assessment of tremor severity from wearable sensor data. We analyzed 25 resting tremor signals from 24 participants (13 PD patients and 11 controls), focusing on motion intensities derived from accelerometer recordings. The k-means clustering algorithm was employed, achieving a classification accuracy of 76% for tremor versus non-tremor states. However, performance decreased for multiclass tremor severity classification (57.1%) and binary classification of severe versus mild tremor (71.4%), highlighting challenges in detecting subtle intensity variations. The findings underscore the utility of unsupervised learning in enabling scalable, objective tremor analysis. Integration of such models into wearable systems could improve continuous monitoring, enhance rehabilitation strategies, and support standardized clinical assessments. Future work should explore advanced algorithms, enriched feature sets, and larger datasets to improve robustness and generalizability.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3390/bioengineering12010037 | DOI Listing |
J Clin Exp Neuropsychol
January 2025
Department of Psychology, University of Illinois at Urbana-Champaign, Champaign, IL, USA.
Introduction: Diagnostic evaluations for attention-deficit/hyperactivity disorder (ADHD) are becoming increasingly complicated by the number of adults who fabricate or exaggerate symptoms. Novel methods are needed to improve the assessment process required to detect these noncredible symptoms. The present study investigated whether unsupervised machine learning (ML) could serve as one such method, and detect noncredible symptom reporting in adults undergoing ADHD evaluations.
View Article and Find Full Text PDFSci Rep
January 2025
Ministry of Higher Education, Mataria Technical College, Cairo, 11718, Egypt.
The current work introduces the hybrid ensemble framework for the detection and segmentation of colorectal cancer. This framework will incorporate both supervised classification and unsupervised clustering methods to present more understandable and accurate diagnostic results. The method entails several steps with CNN models: ADa-22 and AD-22, transformer networks, and an SVM classifier, all inbuilt.
View Article and Find Full Text PDFSensors (Basel)
January 2025
College of Energy and Power Engineering, Xihua University, Chengdu 610039, China.
Artificial intelligence (AI) technologies have been widely applied to the automated detection of pipeline leaks. However, traditional AI methods still face significant challenges in effectively detecting the complete leak process. Furthermore, the deployment cost of such models has increased substantially due to the use of GPU-trained neural networks in recent years.
View Article and Find Full Text PDFInt J Mol Sci
January 2025
St. Catherine Specialty Hospital, 10000 Zagreb, Croatia.
Pharmacogenetics is a branch of genomic medicine aiming to personalize drug prescription guidelines based on individual genetic information. This concept might lead to a reduction in adverse drug reactions, which place a heavy burden on individual patients' health and the economy of the healthcare system. The aim of this study was to present insights gained from the pharmacogenetics-based clustering of over 500 patients from the Croatian population.
View Article and Find Full Text PDFAntibiotics (Basel)
December 2024
Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, 08036 Barcelona, Spain.
The rise of multidrug-resistant (MDR) infections demands personalized antibiotic strategies for febrile neutropenia (FN) in hematological malignancies. This study investigates machine learning (ML) for identifying patient profiles with increased susceptibility to bloodstream infections (BSI) during FN onset, aiming to tailor treatment approaches. From January 2020 to June 2022, we used the unsupervised ML algorithm KAMILA to analyze data from hospitalized hematological malignancy patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!